NST-628

Nested Therapeutics, Inc · Phase 1 active Small molecule

At a glance

Generic name	NST-628
Sponsor	Nested Therapeutics, Inc
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

NST-628 CI brief — competitive landscape report
NST-628 updates RSS · CI watch RSS
Nested Therapeutics, Inc portfolio CI